ASPIRE BIOPHARMA HLDGS INC

Historical 13F Holders

Symbol
ASBP
CUSIP
738920107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 738920107 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Lance Friedman 13G/A 4.5% 5/19/2025
Event 5/6/2025
Harraden Circle Investments, LLC 13G/A
0.3% 5/15/2025
Event 3/31/2025
Ardsley Advisory Partners LP 13G/A
0% 5/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 33.0 $276.00
2026 Q2 1 33.0 $176.00
2026 Q1 2 25.3 k $8.45 k
2025 Q4 30 6.82 M $900 k
2025 Q3 25 3.12 M $646 k
2025 Q2 17 2.04 M $545 k
2025 Q1 16 1.44 M $876 k